Finance

Beta
Lists
28L:FRA
Peptonic Medical AB
€0.00020
0.00%
(0.00) 1D
May 18, 8:21:21 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 28L...
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.00
52-wk low
€0.00
No. of employees
2
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.00
52-wk low
€0.00
No. of employees
2
News stories
From sources across the web
About Peptonic Medical AB
CEOErik Sundquist
Employees2
Founded2009
Headquarters-
SectorPharmaceutical industry
Websitepeptonicmedical.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.91M
2.58M
3.54M
3.40M
Cost of goods sold
129.00K
1.44M
1.37M
1.02M
Cost of revenue
129.00K
1.44M
1.37M
1.02M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.06M
9.28M
10.07M
6.18M
Operating expense
8.27M
10.64M
1.17M
7.71M
Total operating expenses
8.40M
12.08M
2.54M
8.73M
Operating income
-3.49M
-9.50M
998.00K
-5.33M
Other non operating income
-
-102.00K
1.00K
65.00K
EBT including unusual items
-3.54M
-11.24M
-245.00K
-5.68M
EBT excluding unusual items
-3.54M
-11.24M
-245.00K
-5.68M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-1.23M
-90.00K
-10.33M
92.00K
Net income
-3.54M
-11.24M
-245.00K
-5.68M
Net profit margin
-71.98%
-435.50%
-6.92%
-167.37%
Earnings per share
-
-
-
-
Interest and investment income
82.00K
-
16.00K
-
Interest expense
-127.00K
-1.64M
-1.26M
-419.00K
Net interest expenses
-45.00K
-1.64M
-1.24M
-419.00K
Depreciation and amortization charges
1.44M
1.44M
1.43M
1.44M
EBITDA
-3.01M
-9.01M
1.48M
-3.89M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer